Future studies assessing the prognostic and clinicopathological significance of CCND1/cyclin D1 in melanomas should consider the potential biases reported in the present systematic review and meta-analysis, using the QUIPS tool to improve the validity of findings and facilitating comparisons. Here, CCND1 is linked to melanoma.